Human medicines European public assessment report (EPAR): Qarziba (previously Dinutuximab beta EUSA and Dinutuximab beta Apeiron), dinutuximab beta, Neuroblastoma, Date of authorisation: 08/05/2017, Revision: 6, Status: Authorised
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.